Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by E. Genuardi
Novel Molecular Markers for Minimal Residual Disease (Mrd) Monitoring in Mantle Cell and Follicular Lymphoma: The Targeted Locus Amplification (Tla) NGS Strategy
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Minimal Residual Disease by Next-Generation Sequencing in Mantle Cell Lymphoma: The Bioinformatics Tool HashClone
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Related publications
Minimal Residual Disease (Mrd) in Early Stage Follicular Lymphoma Can Predict Prognosis and Drive Rituximab Treatment After Radiotherapy
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Preventing Relapse After Haematopoietic Stem Cell Transplantation for Acute Leukaemia: The Role of Post-Transplantation Minimal Residual Disease (MRD) Monitoring and MRD-directed Intervention
British Journal of Haematology
Hematology
Novel Targeted Strategies to Overcome Microenvironment-Dependent Resistance in Mantle Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Measurable Residual Disease (MRD) Detection by Next Generation Sequencing (NGS) in Acute Lymphoblastic LEUKAEMIA (ALL)
Pathology
Forensic Medicine
Pathology
New Molecular Targets in Mantle Cell Lymphoma
Seminars in Cancer Biology
Cancer Research
Development and Validation of a Quantitative Polymerase Chain Reaction Assay to Evaluate Minimal Residual Disease for T-Cell Acute Lymphoblastic Leukemia and Follicular Lymphoma
American Journal of Pathology
Forensic Medicine
Pathology
A Clofarabine-Based Bridging Regimen in Patients With Relapsed ALL and Persistent Minimal Residual Disease (MRD)
Bone Marrow Transplantation
Transplantation
Hematology
Monitoring of Minimal Residual Disease in Acute Myeloid Leukemia
Cancer
Cancer Research
Oncology
